ALPHA-9 ONCOLOGY — 2271235
Application number
2271235
Registration number
TMA1288460
Type(s)
Standard Characters
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2023-07-24
Registered
2025-02-03
Registration Expiry Date
2035-02-03
Registered Owner
Alpha-9 Oncology Inc.
27 E7th Ave., Suite 300
Vancouver
BRITISH COLUMBIA V5T1M4
Agent
BLAKE, CASSELS & GRAYDON LLP
INTELLECTUAL PROPERTY GROUP
SUITE 4000, COMMERCE COURT WEST
199 BAY STREET
TORONTO
ONTARIO M5L1A9
Documents
Index headings
- ALPHA-9 ONCOLOGY
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations, for the diagnosis and treatment of cancer.
Services (Nice class & Statement)
- 44
- (1) Development and supply of medical services and products in the field of nuclear medicine and imaging and treatment of cancer by use of targeted delivery of a radionuclide.
Recordals (known also as Footnotes)
CHANGE IN TITLE / CHANGEMENT EN TITRE: TYPE OF CHANGE / GENRE DE CHANGEMENT: Name / Nom DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2024-10-25 DATE OF CHANGE / DATE DE CHANGEMENT: 2023-12-08 COMMENTS / COMMENTAIRES: FROM/DE: Alpha-9 Theranostics Inc. TO/A: Alpha-9 Oncology Inc.Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2023-07-24 | ||
| Created | 2023-07-24 | ||
| Formalized | 2023-07-24 | ||
| Pre-Assessment Letter Sent | 2023-09-14 | Goods or Services Not Acceptable | |
| Search Recorded | 2024-10-08 | ||
| Approved | 2024-10-17 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2024-10-17 | APPROVED BY PROGRAM EX200M1 | |
| Amendment to Application | 2024-10-25 | Name/Nom | |
| Advertised | 2024-11-13 | Vol.71 Issue 3655 | |
| Registration Pending | 2025-02-03 | ||
| Registered | 2025-02-03 | 2035-02-03 |